01 1Amoli Organics
01 1TADALAFIL USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-03-20
Pay. Date : 2016-08-19
DMF Number : 30608
Submission : 2016-06-10
Status : Active
Type : II
20
Amoli Organics (a Division Of Umedica Laboratories Pvt Ltd), based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TADALAFIL USP, with a corresponding US DMF Number 30608.
Remarkably, this DMF maintains an Active status since its submission on June 10, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 20, 2018, and payment made on August 19, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
